Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS

The purpose of the present Phase 3 trial is to confirm the efficacy and safety of glepaglutide 10 mg twice weekly in a patient population with SBS-IF and generate additional long-term safety data. Glepaglutide is the International Nonproprietary Name and United States Adopted Name (USAN) for ZP1848.

Participants needed: 90
Trial details
Phase: Phase 3Age: 18-90Biological sex: AllType: InterventionalSponsor: Zealand PharmaUpdated: Apr 20, 2026Locations: 23
Eligibility criteria

Signed informed consent; [+5]

More than 2 SBS- or PS-related hospitalizations within 6 months before screening... [+3]

Status: Recruiting

A Research Study Looking at the Safety of Single and Multiple Doses of ZP9830 and How it Works in the Body of Healthy Participants

The primary object in this research study is to investigate the safety and tolerability of ZP9830 in healthy study participants, and in addition, the study will investigate how ZP9830 works in the body (pharmacokinetics, PK and pharmacodynamics, PD) compared to placebo.

Participants needed: 124
Trial details
Phase: Phase 1Age: 18-45Biological sex: AllType: InterventionalSponsor: Zealand PharmaUpdated: Feb 17, 2026Locations: 1
Eligibility criteria

Healthy participants. [+5]

Evidence of any active or chronic disease or condition that could interfere with... [+5]